- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05688072
Trunk Oriented Exercises Versus Whole-body Vibration for Duchenne Muscular Dystrophy
Trunk Oriented Exercises Versus Whole-body Vibration on Abdominal Thickness and Balance in Children With Duchenne Muscular Dystrophy
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: marwa S saleh
- Phone Number: 01008342466
- Email: marwa_shafiek2000@yahoo.com
Study Contact Backup
- Name: Marwa S Saleh
- Phone Number: 01008342466
- Email: marwa_shafiek2000@cu.edu.eg
Study Locations
-
-
-
Giza, Egypt
- marwa S saleh
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion criteria:
- diagnosed as Duchenne muscular dystrophy,
- aged from 6 to 10 years,
- having grade 3+ muscle strength in lower limbs and trunk muscles.
- had functional range of motion for upper and lower limb joints,
- able to walk alone level I and II of Ambulation function classification system for DMD (AFCSD)
- Exclusion criteria:
- congenital or acquired skeletal deformities or cardiopulmonary dysfunction,
- had undergone previous orthopedic surgery in lower limbs,
- had abnormal motor development or neurological disease that affect balance
- and gait, and
- behavioral problems causing inability to cooperate during the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: study group (A)
|
trunk oriented exercises include: stretching exercises, stabilization exercises (active or active-assisted), arm exercises in fixed trunk position, trunk-oriented exercises (active or active-assisted), trunk mobilization (sitting and lying position), and functional reaching exercises with different ranges of motion in shoulder elevation
|
Active Comparator: Study group (B)
|
WBV application technique.
The children assume a full squatting position on a vibration platform.
The apparatus will set at a frequency of 30 Hz, an amplitude of 2 mm, and a duration of 5 min.
The children were instructed to remain in squatting position after the vibration started and to report any discomfort that arose.
At the end of 5 min, the vibration turned off automatically.
Thereafter, the children rested for 1 min.
They were then asked to stand on the vibration platform while supported by the therapist for 5 min, with the same parameters as those used in the squatting position.
The total time of application of WBV in each session was 10 min.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
abdominal muscle thickness
Time Frame: change from base line at 4 weeks.
|
The thickness of four abdominal muscles will be measured with ultrasonography (device type GE Logiq P6) with a frequency of 7.5 MHz.
The probe will be placed 2 or 3 cm from the midline, using the umbilicus as a landmark, then will be moved in a semi-circular motion until the deepest image on the screen, the TA, will be visible.
To confirm this position and measure the thickness, a skin marker pen will be used.
The probe will be then moved in an oblique manner to detect the thickness of the EO, IO, RA, and TA.
A large amount of contact gel will be used, and the probe pressure will be adjusted to obtain optimal values of muscle thickness.
After image capture, a vertical line will drawn between the superficial and deep aponeurosis to determine muscle thickness.
|
change from base line at 4 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
balance assessment
Time Frame: change from base line at 4 weeks.
|
the Biodex Balance System (BBS) (Biodex medical system, Shirley, New York) will be used for balance assessment. Before the evaluation procedures all children will be given an explanatory session to be aware about the different test steps, also the support rails and biofeedback display screen will be adjusted for each child to ensure comfort and safety during the test procedure, then each child will be trained 1 min for adaptation to the machine. During the test, children will be instructed to stand on the platform in the most comfortable posture, and maintain their visual level by focusing straight ahead on the monitor. The platform will be unlocked and children will be allowed to adjust their foot placement until a comfortable standing position will be achieved while they simultaneously maintained a moving pointer at the center point on the monitor and children will be encouraged to maintain the moving pointer at the center point throughout the test. |
change from base line at 4 weeks.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Treatment of Duchenne syndrome
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Muscular Dystrophy, Duchenne Type
-
Medical University of GdanskRecruitingDuchenne Muscular Dystrophy (DMD)Poland
-
ItalfarmacoCompletedDuchenne Muscular Dystrophy (DMD)Italy
-
Santhera PharmaceuticalsTerminatedDuchenne Muscular Dystrophy (DMD)United States, Spain, Netherlands, Sweden, Germany, France, Belgium, United Kingdom, Italy, Ireland, Switzerland, Austria, Bulgaria, Hungary, Israel
-
Sarepta Therapeutics, Inc.CompletedDuchenne Muscular Dystrophy (DMD)United States
-
Hospital RudolfstiftungOesterreichische MuskelforschungCompletedCarrier of Duchenne Muscular DystrophyAustria
-
General Hospital of Chinese Armed Police ForcesUnknownDuchenne Muscular Dystrophy (DMD)China
-
Chaitanya Hospital, PuneUnknownMuscular Dystrophy | Duchenne Muscular Dystrophy,India
-
University of FloridaU.S. Army Medical Research and Development CommandRecruitingDuchenne Muscular Dystrophy (DMD)United States
-
PTC TherapeuticsCompletedNonsene Mutation Duchenne Muscular DystrophyUnited States
-
Ondokuz Mayıs UniversityCompletedDuchenne Muscular Dystrophy (DMD)Turkey
Clinical Trials on trunk oriented exercise
-
Gokce Yagmur Gunes GencerHacettepe UniversityCompletedMuscular Dystrophy, Duchenne | Upper Extremity | Respiratory FunctionsTurkey
-
Centre for Interdisciplinary Research in Rehabilitation...Mitacs; Neuro-Concept Inc.RecruitingSpinal Cord InjuriesCanada
-
Universidade Federal do PiauíCompletedTransversus Abdominis ActivationBrazil
-
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical...Taipei Medical UniversityCompletedStroke | Balancing Interference | Walking, DifficultyTaiwan
-
Khon Kaen UniversityCompleted
-
Inje UniversityUnknown
-
Riphah International UniversityRecruitingSpastic Cerebral PalsyPakistan
-
University of VermontEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
Lithuanian Sports UniversityCompletedHip Injuries | Hip Replacement | CoxarthrosisLithuania
-
Bundang CHA HospitalNot yet recruiting